Katsuda et al. proposed the use of adipose tissue-derived MSC-EVs as a promising approach to delivering the most important β amyloid (Aβ)-degrading enzyme neprilysin (NEP) peripherally and/or directly into the brain in AD [122]. Here, MME is linked to Alzheimer disease.